H. Jeffrey Wilkins, Chief Medical Officer at Avalo Therapeutics, Inc. (AVTX), bought 6,371 shares at $1.57 ($10K) on 2021-12-10, disclosed to the SEC on 2021-12-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.